| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Notice of Annual General Meeting 2024
|
18 Nov 2024 9:44AM |
$3.030 |
$2.590 |
fallen by
14.52%
|
|
| Riversgold Limited (RGL) ORDINARY FULLY PAID |
Materials |
$7 |
Trading Halt
|
18 Nov 2024 9:43AM |
$0.004 |
$0.004 |
risen by
14.29%
|
|
RGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Riversgold Ltd requested a trading halt effective immediately.
- The halt is pending the release of an announcement regarding exploration results.
- The trading halt will last until November 20, 2024, or until the announcement is released.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ronin Resources Ltd (RON) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - RON
|
18 Nov 2024 9:43AM |
$0.180 |
$0.150 |
fallen by
16.67%
|
|
| Ronin Resources Ltd (RON) ORDINARY FULLY PAID |
Materials |
$6 |
Placement to Advance Exploration in San Juan, Argentina
|
18 Nov 2024 9:43AM |
$0.180 |
$0.150 |
fallen by
16.67%
|
|
RON - Price-sensitive ASX Announcement
Full Release
Key Points
- $461,500 placement supported by existing shareholders
- Focus on La Punilla Gold-Silver Project in San Juan, Argentina
- San Juan hosts the Veladero gold-silver mine and giant copper-gold deposits
- Ronin's Chairman is also President & CEO of Pampa Metals
- Jordan Webster appointed as Country Manager for Argentina
- Funds will support initial exploration and business development
- Placement involves issuing 3.55 million shares at $0.13 each
- Investors receive 1 attaching option per share, exercisable at $0.25
- Expectation that exploration applications will be granted within 3 months
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Unity Office Property Fund (AOF) ORDINARY UNITS FULLY PAID |
Real Estate |
$76 |
Settlement of 64 Northbourne Ave and Special Distribution
|
18 Nov 2024 9:43AM |
$1.215 |
$0.460 |
fallen by
62.14%
|
|
| The Original Juice Co. Limited (OJC) ORDINARY FULLY PAID |
Consumer Staple |
- |
Update - Consolidation/Split - OJC
|
18 Nov 2024 9:43AM |
$0.180 |
$0.180 |
fallen by
0%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$16 |
Notification regarding unquoted securities - RHY
|
18 Nov 2024 9:42AM |
$0.115 |
$0.056 |
fallen by
51.30%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$16 |
Notification regarding unquoted securities - RHY
|
18 Nov 2024 9:42AM |
$0.115 |
$0.056 |
fallen by
51.30%
|
|
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$708 |
Weekly NTA 15.11.2024
|
18 Nov 2024 9:41AM |
$2.860 |
$3.180 |
risen by
11.19%
|
|
| New Talisman Gold Mines Limited (NTL) ORDINARY FULLY PAID |
Materials |
- |
NTL Proposed Voluntary Delisting from ASX
|
18 Nov 2024 9:41AM |
$0.019 |
$0.016 |
fallen by
15.79%
|
|
NTL - Price-sensitive ASX Announcement
Full Release
Key Points
- NTL has submitted a request for voluntary delisting from the ASX.
- The ASX has confirmed the delisting will occur subject to certain conditions.
- NTL's primary listing will continue on the NZX.
- The delisting is due to high costs and low trading volumes on the ASX.
- The majority of NTL shareholders are based in New Zealand.
- NTL will establish an unmarketable parcel sale facility for small retail shareholders.
- Shareholders can trade their shares on the NZX after the ASX delisting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metals X Limited (MLX) ORDINARY FULLY PAID |
Materials |
$554 |
Ringrose Exploration Update
|
18 Nov 2024 9:41AM |
$0.435 |
$0.625 |
risen by
43.68%
|
|
MLX - Price-sensitive ASX Announcement
Full Release
Key Points
- A subsequent Phase 2 diamond drilling program comprising seven drill holes for 6,246m commenced in August 2022 to test other 2019 DHEM conductors.
- Drill hole S1671 intersected 26.93m @ 4.57% Sn from 225.07m.
- Following the initial discovery, 20 additional drill holes for 10,238m were completed at Ringrose.
- Assay results from 14 of the drill holes were reported in previous ASX releases.
- Significant Sn assay results include S1709: 28.5m at 1.61% Sn from 277.9m.
- Three surface diamond drill rigs are currently operational at Renison.
- The area is expected to be developed with minimal additional surface infrastructure due to its proximity to existing mining operations.
- The ongoing drilling is anticipated to contribute to the planned 2025 Mineral Resource estimate for Ringrose.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catapult Group International Limited (CAT) ORDINARY FULLY PAID |
Information Technology |
$1,813 |
Ceasing to be a substantial holder
|
18 Nov 2024 9:41AM |
$3.000 |
$6.390 |
risen by
113%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$152 |
EIQ signs integration agreement with Flagship US Hospital
|
18 Nov 2024 9:40AM |
$0.225 |
$0.235 |
risen by
4.44%
|
|
EIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Integration agreement secured with Beth Israel Deaconess Medical Center.
- Integration follows successful trial of EchoSolv-AS by Beth Israel researchers.
- Trial validated technology's accuracy and potential for identifying aortic stenosis patients.
- Beth Israel conducts 30,000 echocardiograms annually.
- Echo IQ's flagship deployment in the USA post FDA clearance.
- Integration allows BIDMC to use EchoSolv-AS at no cost while reimbursement codes are pursued.
- EchoSolv-AS identified 98% of patients meeting severe aortic stenosis guidelines.
- Clinical trial findings published in JACC Advances.
- Further deployments are expected as Echo IQ engages with additional US hospital groups.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| One Click Group Limited (1CG) ORDINARY FULLY PAID |
Industrials |
$12 |
Notice of General Meeting/Proxy Form
|
18 Nov 2024 9:40AM |
$0.013 |
$0.010 |
fallen by
23.08%
|
|
| Norfolk Metals Limited (NFL) ORDINARY FULLY PAID |
Materials |
$8 |
Orroroo Project Update
|
18 Nov 2024 9:39AM |
$0.110 |
$0.155 |
risen by
40.91%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$642 |
Weekly Estimate NTA for 15.11.2024
|
18 Nov 2024 9:37AM |
$3.600 |
$3.010 |
fallen by
16.39%
|
|
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,329 |
Head-to-head IIT with SAR-bisPSMA
|
18 Nov 2024 9:36AM |
$7.140 |
$4.110 |
fallen by
42.44%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals is conducting a head-to-head trial comparing 64Cu-SAR-bis-PSMA and 68Ga-PSMA-11.
- The trial is named Co-PSMA and involves 50 patients with biochemical recurrence of prostate cancer.
- Prof Louise Emmett is the lead investigator for the trial at St Vincent’s Hospital, Sydney.
- The primary goal is to compare the detection rates of prostate cancer recurrence between the two diagnostic products.
- Clarity aims to demonstrate the superior capabilities of their copper-based diagnostic over current-generation standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elders Limited (ELD) ORDINARY FULLY PAID |
Consumer Staple |
$1,375 |
Cleansing Notice
|
18 Nov 2024 9:35AM |
$8.650 |
$7.190 |
fallen by
16.88%
|
|
| Connected Minerals Limited (CML) ORDINARY FULLY PAID |
Information Technology |
$5 |
Uranium Mineralisation Found in Sampling Done at Etango NE
|
18 Nov 2024 9:35AM |
$0.185 |
$0.130 |
fallen by
29.73%
|
|
CML - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade U3O8 mineralisation confirmed at Etango North-East Project.
- Significant rock chip results include: 2,086 ppm U3O8 from sample CMRS4.
- Initial exploration program expanded to include additional sampling and surveys.
- Area of focus based on historic uranium scintillometer readings.
- Exploration team led by Herbert Roesener, a geologist with 40 years of experience.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elders Limited (ELD) ORDINARY FULLY PAID |
Consumer Staple |
$1,375 |
Proposed issue of securities - ELD
|
18 Nov 2024 9:35AM |
$8.650 |
$7.190 |
fallen by
16.88%
|
|
| Elders Limited (ELD) ORDINARY FULLY PAID |
Consumer Staple |
$1,375 |
Proposed issue of securities - ELD
|
18 Nov 2024 9:35AM |
$8.650 |
$7.190 |
fallen by
16.88%
|
|
| Elders Limited (ELD) ORDINARY FULLY PAID |
Consumer Staple |
$1,375 |
Acquisition of Delta Agri & Equity Raise Presentation
|
18 Nov 2024 9:35AM |
$8.650 |
$7.190 |
fallen by
16.88%
|
|
ELD - Price-sensitive ASX Announcement
Full Release
Key Points
- Elders is acquiring Delta Agribusiness for $475 million.
- The acquisition will be funded with cash and an equity raising of approximately $246 million.
- Delta's business model complements Elders' existing offerings in rural products.
- Expected synergies from the acquisition are about $12 million annually over three years.
- The equity raising includes a pro-rata entitlement offer to existing shareholders.
- Completion of the acquisition is anticipated in the first half of 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alderan Resources Limited (AL8) ORDINARY FULLY PAID |
Materials |
$5 |
Lab Assays Confirm New Years Copper Oxide Deposit Potential
|
18 Nov 2024 9:35AM |
$0.003 |
$0.026 |
risen by
766.67%
|
|
AL8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Alderan drilling confirms shallow high grade copper oxide at New Years, Utah.
- Hole NY2024-DDH3 intersected 26m @ 1.31% copper from surface.
- Hole NY2024-DDH2 intersected 30m @ 0.78% copper from 10m down hole.
- Maximum copper assays of 3.2% and 4.6% in NY2024-DDH2 and NY2024-DDH3 respectively.
- Mineralisation consistent with historical drill holes NY-2 and NY-6.
- Copper mineralisation occurs in tourmaline breccia similar to the Cactus copper-gold deposit.
- Twelve follow-up targets identified for further exploration.
- Geological mapping and soil sampling planned for further investigation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elders Limited (ELD) ORDINARY FULLY PAID |
Consumer Staple |
$1,375 |
Acquisition of Delta Agribusiness and Equity Raising
|
18 Nov 2024 9:35AM |
$8.650 |
$7.190 |
fallen by
16.88%
|
|
ELD - Price-sensitive ASX Announcement
Full Release
Key Points
- Elders Limited is acquiring 100% of Delta Agribusiness for $475 million.
- Delta generated revenue of $835 million and EBITDA of $53 million for the year ending June 2024.
- The acquisition will fill retail gaps in key regions and enhance Elders' expertise in ag tech and precision agriculture.
- Expected annual net EBITDA synergies of $12 million to be realized over three years post acquisition.
- The transaction will be funded through a mix of equity raising, debt financing, and scrip consideration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TZ Limited (TZL) ORDINARY FULLY PAID |
Information Technology |
$13 |
Change of Director's Interest Notice
|
18 Nov 2024 9:35AM |
$0.069 |
$0.048 |
fallen by
30.43%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
